HRYZ-T102 TCR-T Cell

· Shanghai Ruiliyuan Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRYZ-T102 TCR-T Cell, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors [Phase 1]